The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma
The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma
Active, not recruiting · NCT05144087 · Registry updated 2025-02-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Active, not recruiting | Not stated | 2025-02-19 | NCT05144087 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| King's College Hospital NHS Trust | 77 |
| University Hospital Southampton NHS Foundation Trust | 59 |
| University of Southampton | 60 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NIHR Clinical Research Facility | Southampton | United Kingdom | 1 |